AEON Biopharma, Inc. - 8-K Filing

AEON Biopharma completed a partial exercise of the over-allotment option in its public offering on July 23, 2026. (Items: 8.01 Other Events)

SEC EDGAR ·

Tickers: $AEON

Read the full article at SEC EDGAR

More Regulatory news